Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

The methylenetetrahydrofolate reductase C677T polymorphism influences risk of esophageal cancer in Chinese.

Qu HH, Cui LH, Wang K, Wang P, Song CH, Wang KJ, Zhang JY, Dai LP.

Asian Pac J Cancer Prev. 2013;14(5):3163-8.

2.
3.

Folate intake, methylenetetrahydrofolate reductase polymorphisms, and risk of esophageal cancer.

Zhao P, Lin F, Li Z, Lin B, Lin J, Luo R.

Asian Pac J Cancer Prev. 2011;12(8):2019-23.

4.

Methylenetetrahydrofolate reductase C677T polymorphism and predisposition towards esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.

Zhang J, Zotz RB, Li Y, Wang R, Kiel S, Schulz WA, Wen D, Chen Z, Zhang L, Wang S, Gabbert HE, Sarbia M.

J Cancer Res Clin Oncol. 2004 Oct;130(10):574-80. Epub 2004 Jul 29.

PMID:
15449187
5.

[Study on the ingestion of folate and polymorphism of MTHFR C677T with esophageal cancer in Xinjiang Kazakh].

Qin JM, Wang XM, Chen B, Yang L, Li F, He L, Liao PH.

Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Jan;29(1):30-3. Chinese.

PMID:
18785474
6.
7.

Allele and Genotype Frequencies of the Polymorphic Methylenetetrahydrofolate Reductase and Lung Cancer in ther Jordanian Population: a Case Control Study.

Al-Motassem Y, Shomaf M, Said I, Berger S, Ababneh N, Diab O, Obeidat N, Awidi A.

Asian Pac J Cancer Prev. 2015;16(8):3101-9.

8.

Methylenetetrahydrofolate reductase genotypes and haplotypes associated with susceptibility to colorectal cancer in an eastern Chinese Han population.

Li H, Xu WL, Shen HL, Chen QY, Hui LL, Long LL, Zhu XL.

Genet Mol Res. 2011 Dec 14;10(4):3738-46. doi: 10.4238/2011.December.14.8.

9.

A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in breast cancer.

Zhong S, Chen Z, Yu X, Li W, Tang J, Zhao J.

Mol Biol Rep. 2014 Sep;41(9):5775-85. doi: 10.1007/s11033-014-3450-9. Epub 2014 Jun 29.

PMID:
24973876
10.
11.

Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer.

Cao HX, Gao CM, Takezaki T, Wu JZ, Ding JH, Liu YT, Li SP, Su P, Cao J, Hamajima N, Tajima K.

Asian Pac J Cancer Prev. 2008 Apr-Jun;9(2):203-8.

12.

Association study between methylenetetrahydrofolate reductase polymorphisms and unexplained recurrent pregnancy loss: a meta-analysis.

Cao Y, Xu J, Zhang Z, Huang X, Zhang A, Wang J, Zheng Q, Fu L, Du J.

Gene. 2013 Feb 10;514(2):105-11. doi: 10.1016/j.gene.2012.10.091. Epub 2012 Nov 29.

PMID:
23201418
13.

Association between MTHFR C677T polymorphism and depression: An updated meta-analysis of 26 studies.

Wu YL, Ding XX, Sun YH, Yang HY, Chen J, Zhao X, Jiang YH, Lv XL, Wu ZQ.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:78-85. doi: 10.1016/j.pnpbp.2013.06.015. Epub 2013 Jul 4.

PMID:
23831680
14.

Association between methylenetetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: a meta-analysis.

Wu YL, Yang HY, Ding XX, Zhao X, Chen J, Bi P, Sun YH.

Seizure. 2014 Jun;23(6):411-6. doi: 10.1016/j.seizure.2014.01.018. Epub 2014 Feb 2.

15.

Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer in a Korean population.

Cui LH, Shin MH, Kweon SS, Kim HN, Song HR, Piao JM, Choi JS, Shim HJ, Hwang JE, Kim HR, Park YK, Kim SH.

BMC Cancer. 2010 May 26;10:236. doi: 10.1186/1471-2407-10-236.

16.

Association of the MTHFR C677T polymorphism with primary brain tumor risk.

Xu C, Yuan L, Tian H, Cao H, Chen S.

Tumour Biol. 2013 Dec;34(6):3457-64. doi: 10.1007/s13277-013-0922-9. Epub 2013 Jul 12.

PMID:
23846816
17.

The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: Evidence from 23 case-control studies.

Guo S, Jiang X, Chen X, Chen L, Li X, Jia Y.

Gene. 2015 Jul 1;565(1):90-5. doi: 10.1016/j.gene.2015.03.067. Epub 2015 Apr 2.

PMID:
25841988
18.
19.
20.

Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and fluorouracil-based treatment in Taiwan colorectal cancer.

Wu NC, Su SM, Lin TJ, Chin J, Hou CF, Yang JY, Liu WS, Chang LC.

Anticancer Drugs. 2015 Sep;26(8):888-93. doi: 10.1097/CAD.0000000000000261.

PMID:
26111049

Supplemental Content

Support Center